As UAG reduces prostate cancer proliferation in vitro [14] and has potential beneficial metabolic effects in vivo, we examined the effect of UAG in our model of metabolic dysfunction: Rag1-/- mice fed a high-fat diet with subcutaneous prostate cancer cell line xenografts [69]. The gene discussed is RAG1; the disease is prostate carcinoma.